Xiaoping Tang | FRP in Health & Medicine | Best Researcher Award

Assist. Prof. Dr. Xiaoping Tang | FRP in Health & Medicine | Best Researcher Award

Assistant Professor Doctorate at The Second Affiliated Hospital of Nanchang University, China

Profile:

Current Position 🌟

Dr. Xiaoping Tang currently serves as an Associate Professor at the Medical Imaging Center of The Second Affiliated Hospital of Nanchang University, Nanchang, China. He also holds the position of Deputy Chief Physician in the Department of Radiology. With expertise in imaging medicine and nuclear medicine, Dr. Tang actively contributes to advancing diagnostic radiology, teaching, and innovative research.

Academic Background 🎓

Dr. Tang’s impressive academic journey reflects his dedication to medicine and research. He is pursuing a PhD in Biomedical Engineering at Tsinghua University, Beijing, since 2023. He earned his MD Degree in Clinical Medicine (2012–2016) and a Master’s Degree in Imaging Medicine and Nuclear Medicine (2006–2009) from Nanchang University. His academic foundation was laid with an Undergraduate Degree in Imaging Medicine and Nuclear Medicine (1999–2004) from the same institution, demonstrating his long-standing commitment to medical imaging sciences.

Professional Experience 🏥

Dr. Tang’s career spans over two decades, combining clinical expertise, academic involvement, and leadership.

  • 2016–Present: Deputy Chief Physician, Department of Radiology, The Second Affiliated Hospital of Nanchang University.
  • 2019–Present: Associate Professor, Medical Imaging Center, The Second Affiliated Hospital of Nanchang University.
  • 2010–2015: Attending Physician, Radiology Department, The Second Affiliated Hospital of Nanchang University.
  • 2004–2006: Residency Training, Jinhua City Traditional Chinese Medicine Hospital.

Research Interests 🔬

  • Medical Imaging: Advancing imaging techniques for better diagnostics.
  • Nuclear Medicine: Exploring innovative applications in diagnostic radiology.
  • Alzheimer’s Disease Imaging: Member of the China Alzheimer’s Disease Prevention and Treatment Association, working on imaging techniques for neurodegenerative disorders.
  • Infectious Disease Imaging: As part of Beijing Imaging Technology Innovation Alliance, his research supports the development of advanced diagnostic tools for infectious diseases.

Publication Achievements 📚

Dr. Tang has contributed extensively to scholarly research. While specific publications were not listed, his work spans radiology, imaging medicine, and nuclear medicine. As a reviewer for esteemed journals like Frontiers in Neurology and the China Journal of CT and MRI, he ensures high-quality scientific dissemination.

Ongoing Research and Innovation 🔎

Dr. Tang actively leads studies on emergency imaging and innovative radiology technologies. His pioneering efforts in developing new imaging techniques have earned him recognition, including the New Technology Awards at The Second Affiliated Hospital of Nanchang University in 2021 and 2022.

Honors and Awards 🏆

  • Third Prize, Jiangxi Province Science and Technology Progress Award.
  • Third Prize, Jiangxi Province Medical Science and Technology Award.
  • New Technology Awards, The Second Affiliated Hospital of Nanchang University (2021, 2022).

Professional Associations 🌍

  • Member, Radiology Branch of the Chinese Medical Association.
  • Youth Committee Member, China Research Hospital Association.
  • Member, Imaging Professional Committee of China Alzheimer’s Disease Prevention and Treatment Association.
  • Member, Medical Imaging Branch of Jiangxi Province Research Hospital Association.

Teaching Responsibilities 📖

Dr. Tang is deeply committed to education, mentoring future radiologists-Courses taught: Medical Imaging and Emergency Imaging at Nanchang University.

Editorial Responsibilities and Peer Review ✏️

Dr. Tang is a respected reviewer for leading journals, including:

  • Frontiers in Neurology.
  • China Journal of CT and MRI.

Success Factors and Key Contributions ✨

Dr. Tang’s ability to balance clinical practice, academic responsibilities, and cutting-edge research defines his success. His leadership in radiology and innovative imaging techniques significantly contributes to advancements in diagnostics and treatment planning.

Future Goals and Legacy 🚀

With his ongoing PhD studies and dedication to imaging innovations, Dr. Tang aims to drive breakthroughs in biomedical engineering. His work promises to leave a lasting impact on radiology, advancing diagnostic capabilities worldwide.

📖Publications:

Paper Title: Alterations in the DTI-ALPS index and choroid plexus volume are associated with clinical symptoms in participants with narcolepsy type 1

  • Authors: Hu, P.; Yuan, Y.; Zou, Y.; Xie, L.; Tang, X.
  • Journal: Sleep Medicine
  • Year: 2024

Paper Title: Clinical and magnetic resonance imaging features of Trousseau’s syndrome with acute cerebral infarction

  • Authors: Xiong, R.; Li, C.; Zhu, H.; Tang, X.
  • Journal: Academic Journal of Naval Medical University
  • Year: 2024

Paper Title: The prognostic value of ASPECTS in specific regions following mechanical thrombectomy in patients with acute ischemic stroke from large-vessel occlusion

  • Authors: Zou, Y.; Tu, J.; Hu, P.; Zhao, X.; Tang, X.
  • Journal: Frontiers in Neurology
  • Year: 2024

Paper Title: Clinical value of high‑resolution vessel wall imaging and silent magnetic resonance angiography in re‑examination after intracranial aneurysm embolization

  • Authors: Zeng, Z.; Zhang, Z.; Tang, X.; Xu, S.; Gong, L.
  • Journal: Chinese Journal of Neurology
  • Year: 2023

Paper Title: Radiomics features based on T2-weighted fluid-attenuated inversion recovery MRI predict the expression levels of CD44 and CD133 in lower grade gliomas

  • Authors: Wang, Z.; Tang, X.; Wu, J.; Chen, S.; Xiao, X.
  • Journal: Future Oncology
  • Year: 2022

 

Qian Zhang | FRP in Health & Medicine | Best Researcher Award

Prof. Qian Zhang | FRP in Health & Medicine | Best Researcher Award

Professor at Hong Kong University of Science and Technology (HKUST), Hong Kong

Profiles:

Current Position and Leadership Roles 🏛️

Qian Zhang, a Fellow of IEEE (FIEEE) and Hong Kong Academy of Engineering Sciences (FHKEng), holds several prestigious positions at the Hong Kong University of Science and Technology (HKUST). She is the Acting Head of the Integrative System and Design (ISD) Division (since 2024) and serves as the Tencent Professor of Engineering. She is also a Chair Professor in the Department of Computer Science and Engineering (CSE). As the Founding Director of the Huawei-HKUST Innovation Lab and the Digital Life Research Center, her work integrates cutting-edge technology with practical applications. Additionally, she leads the HKUST MOE/MSRA Information Technology Key Laboratory, solidifying her reputation as a transformative leader in technology and education.

Publication Achievements 📚

Qian Zhang has an extensive portfolio of impactful publications. Her work spans high-impact journals and top-tier conferences, focusing on areas such as AI and Internet of Things (AIoT), cognitive radio networks, and next-generation wireless networks. Her interdisciplinary research, blending machine learning and data analytics, has resulted in groundbreaking contributions to mobile computing, smart healthcare, and cybersecurity. Zhang’s publications are highly cited, reflecting their influence in the global academic and industrial landscapes.

Ongoing Research 🌐

Currently, Qian Zhang is deeply engaged in interdisciplinary research that bridges AI, sensing technologies, and advanced networking systems. AIoT and Smart Healthcare-Leveraging AI for intelligent healthcare systems. Cybersecurity and Blockchain Infrastructure-Enhancing secure and scalable network systems. Dynamic Spectrum Management-Innovating in cognitive radio networks to optimize wireless spectrum usage. Multimedia Delivery-Improving content distribution over diverse platforms, including wireless Internet. Her research emphasizes algorithm development, system implementation, and validation through real-world scenarios, ensuring practical relevance and technological impact.

Research Interests 🔬

AI and IoT applications in healthcare. Cybersecurity and advanced blockchain systems. Mobile computing and dynamic spectrum management. Network economics and next-generation wireless technologies. Multimedia delivery optimization. Her interdisciplinary approach integrates sensing modalities, machine learning, and robust analytics to address challenges in technology and society.

Academic Background 🎓

Qian Zhang earned her B.S. and Ph.D. in Computer Science from Wuhan University, China, between 1990 and 1999. Her doctoral research laid the foundation for her prolific career in computer science, especially in AI and networking.

Scholarships and Awards 🏆

Recognized globally for her contributions, Qian Zhang has received numerous accolades,  Fellowships in IEEE and FHKEng. Prestigious professorships, such as the Changjiang Chair Professorship. Leadership roles in transformative research labs and key technology centers.

Professional Associations 🌟

As a Fellow of IEEE and FHKEng, Qian Zhang plays a significant role in shaping the future of engineering and computer science. She is an active member of professional networks that foster innovation and collaboration.

Training & Workshops 📖

Qian Zhang has participated in and organized numerous workshops and training programs, focusing on emerging trends in AI, IoT, and wireless technologies. Her efforts include training the next generation of researchers and practitioners through interdisciplinary workshops.

Oral Presentations and Conferences 🎤

A sought-after speaker, Zhang has delivered keynote presentations at international conferences and symposia. Her talks often explore innovative solutions in AI, network security, and mobile computing, inspiring peers and fostering collaborations.

Tasks Completed as a Researcher 🛠️

Throughout her career, Zhang has achieved remarkable milestones, Development of secure, scalable network infrastructures. Advancements in cognitive radio networks and dynamic spectrum management. Implementation of AI-driven solutions in healthcare and multimedia delivery systems.

Success Factors 🌈

Her success can be attributed to her interdisciplinary research style, combining robust algorithmic foundations with practical implementation. Zhang’s ability to bridge theory and application has set her apart in the fields of AI, networking, and cybersecurity.

Laboratory Experience 🔬

Zhang’s laboratory work emphasizes practical solutions, integrating theoretical research with system validation. Her publications showcase her expertise in real-world applications, ranging from healthcare to next-gen wireless systems.

Legacy and Future Contributions 🚀

Qian Zhang’s contributions continue to shape the fields of computer science and engineering. Her leadership, innovative research, and global impact mark her as a visionary, inspiring future generations in academia and industry.

📖Publications:

Paper Title: Contactless Arterial Blood Pressure Waveform Monitoring with mmWave Radar

  • Authors: Hu, Q., Zhang, Q., Lu, H., Chen, Y.-C., Zhao, N.
  • Journal: Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies
  • Year: 2024

Paper Title: KneeGuard: A Calibration-free Wearable Monitoring System for Knee Osteoarthritis Gait Re-training via Effortless Wearing

  • Authors: Yang, B., Zhang, X., Zhang, J., Hu, H., Zhang, Q.
  • Journal: Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies
  • Year: 2024

Paper Title: BP3: Improving Cuff-less Blood Pressure Monitoring Performance by Fusing mmWave Pulse Wave Sensing and Physiological Factors

  • Authors: Zheng, Z., Liang, Y., Lyu, R., Tang, Y., Zhang, Q.
  • Journal: SenSys 2024 – Proceedings of the 2024 ACM Conference on Embedded Networked Sensor Systems
  • Year: 2024

Paper Title: DeepBreath: Breathing Exercise Assessment with a Depth Camera

  • Authors: Xie, W., Xu, C., Gong, Y., Zheng, Z., Yang, S.
  • Journal: Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies
  • Year: 2024

Paper Title: Spectrum Sensing Everywhere: Wide-Band Spectrum Sensing with Low-Cost UWB Nodes

  • Authors: Luo, Z., Huang, Q., Chen, X., Chen, G., Zhang, Q.
  • Journal: IEEE/ACM Transactions on Networking
  • Year: 2024

 

Wenzhi Tian | FRP in Health & Medicine | Best Researcher Award

Dr. Wenzhi Tian | FRP in Health & Medicine | Best Researcher Award

Doctorate at ImmuneOnco Biopharmaceuticals Shanghai Inc, China

Profile:

Current Position 👨‍💼

Dr. Tian Wenzhi serves as the Chairman of the Board, Chief Executive Officer, Chief Scientific Officer, and Executive Director of his Group. Since founding the company in June 2015, he has led its strategic planning, business management, and research and development efforts. Under his leadership, the Group has emerged as a driving force in biomedical innovation, spearheading projects from discovery to clinical studies. Dr. Tian also oversees subsidiaries like ImmuneTANK, ImmuneOnco Shanghai, Macroimmune, ImmuneOnco Hong Kong, and ImmuneCare.

Publication Achievements 🔖

Dr. Tian’s research contributions have been significant in the biomedical domain, with his work focusing on monoclonal antibody drugs and novel tumor targets. His scientific publications include advancements in B cell functions and breakthroughs in tumor immunology, many of which are widely cited and recognized in international journals. His ability to translate complex research into actionable therapies underscores his contribution to the scientific community.

Ongoing Research 🧬

Dr. Tian’s ongoing research is concentrated on antitumor antibody drugs, autoimmune diseases, and cancer immunotherapy. His innovative approaches involve leveraging cutting-edge bioinformatics tools to identify and validate new drug targets. This ensures precision and effectiveness in therapeutic development, particularly in addressing unmet needs in oncology and immunology.

Research Interests 🌐

Dr. Tian’s research interests encompass a wide array of fields, Cancer Immunotherapy-Developing monoclonal antibodies to target specific tumor pathways. Bioinformatics-Using computational techniques to analyze biological data for drug discovery. Autoimmune Diseases-Investigating the molecular basis and potential therapeutic interventions. CMC Development-Overseeing Chemistry, Manufacturing, and Controls to ensure drug safety and efficacy.

Academic Background 🎓

Dr. Tian’s academic journey began at the Medical School of Zhengzhou University, where he served as a teaching assistant from 1990 to 1993. He later pursued advanced research at Weill Cornell Medical College, focusing on c-Rel regulated genes in B cell functions. This foundational work laid the groundwork for his illustrious career in biomedical research.

Scholarships and Awards 🏆

Dr. Tian’s dedication has earned him prestigious recognitions, Senior Biomedical Engineer Certification by Shanghai Municipal Human Resources and Social Security Bureau (2019). Visiting and distinguished professorships at Zhengzhou University, Henan Medical University, and Fudan University, highlighting his academic and industry leadership.

Bioinformatics Expertise 🔄

Dr. Tian integrates bioinformatics into his research to streamline drug discovery processes. By employing computational tools, he enhances the precision of target selection and validation, contributing to the development of science-driven solutions for complex diseases.

Professional Associations 📚

Dr. Tian actively participates in several biomedical and scientific societies, fostering collaboration and staying at the forefront of emerging trends. His memberships underscore his commitment to advancing global healthcare through research.

Training & Workshops 🏢

Throughout his career, Dr. Tian has organized and participated in numerous international workshops and training sessions, focusing on monoclonal antibody development, clinical studies, and advanced manufacturing techniques. These initiatives have enriched his expertise and disseminated knowledge across the industry.

Oral Presentations📈

Dr. Tian has delivered impactful presentations at prestigious conferences worldwide, Innovative approaches to antibody drug development. The role of c-Rel genes in immune regulation. Strategies for effective clinical trial management.

Tasks Completed as a Researcher 🔄

Dr. Tian’s career is marked by significant achievements, Establishing a robust pipeline for antitumor drug discovery. Cloning and studying critical genes involved in B cell function. Leading CMC development and ensuring regulatory compliance. Overseeing multiple clinical studies that advance therapeutic applications.

Success Factors 🌟

Dr. Tian attributes his success to a combination of visionary leadership, a science-driven approach, and collaborative partnerships. His ability to bridge the gap between academic research and clinical application has been instrumental in his Group’s success.

Laboratory Experience 🔧

Dr. Tian’s extensive laboratory experience spans over three decades. From cloning genes at Weill Cornell Medical College to leading monoclonal antibody research at ImClone Systems, his hands-on expertise has shaped cutting-edge therapies. His publications, often resulting from meticulous lab work, are testaments to his enduring contribution to biomedical science.

Conclusion 🖖

Dr. Tian Wenzhi’s illustrious career is a testament to his unwavering commitment to biomedical innovation. From pioneering research to fostering global collaborations, his work continues to make a profound impact on healthcare and science. Through his leadership, vision, and dedication, Dr. Tian exemplifies the transformative power of scientific discovery.

📖Publications:

Paper Title: Development of bioassay platforms for biopharmaceuticals using Jurkat-CAR cells by AICD

  • Authors: Chen, D.; Li, S.; Yang, Y.; Zhang, R.; Tian, W.
  • Journal: Journal of Pharmaceutical and Biomedical Analysis
  • Year: 2024

Paper Title: IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy

  • Authors: Yang, C.; Li, S.; Chen, D.; Tu, X.; Tian, W.
  • Journal: Heliyon
  • Year: 2024

Paper Title: Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy

  • Authors: Zhang, B.; Shi, J.; Shi, X.; Xu, L.; Li, W.
  • Journal: Drug Resistance Updates
  • Year: 2024

Paper Title: Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

  • Authors: Li, X.; Tian, W.; Jiang, Z.; Leng, X.; Yu, J.
  • Journal: Cancer Immunology, Immunotherapy
  • Year: 2024

Paper Title: DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

  • Authors: Liu, L.; Gong, D.; Sun, H.; An, G.; Hao, M.
  • Journal: Frontiers in Immunology
  • Year: 2024